Literature DB >> 20554044

Measuring HIV fusion mediated by envelopes from primary viral isolates.

Marielle Cavrois1, Jason Neidleman, Nicole Galloway, Cynthia A Derdeyn, Eric Hunter, Warner C Greene.   

Abstract

Over the course of infection, the human immunodeficiency virus type 1 (HIV-1) continuously adapts in part to evade the host's neutralizing antibody response. Antibodies often target the HIV envelope proteins that mediate HIV fusion to its cellular targets. HIV virions pseudotyped with primary envelopes have often been used to explore the fusogenic properties of these envelopes. Unfortunately, these pseudotyped virions fuse with greatly reduced efficiency to primary cells. Here, we describe a relatively simple strategy to clone primary envelopes into a provirus and increase the sensitivity of the virion-based fusion assay. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554044      PMCID: PMC3563671          DOI: 10.1016/j.ymeth.2010.05.010

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  43 in total

1.  T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells.

Authors:  Thomas Neumann; Isabel Hagmann; Sabine Lohrengel; Marintha L Heil; Cynthia A Derdeyn; Hans-Georg Kräusslich; Matthias T Dittmar
Journal:  Virology       Date:  2005-03-15       Impact factor: 3.616

2.  Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.

Authors:  Akihito Yonezawa; Marielle Cavrois; Warner C Greene
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques.

Authors:  W M Blay; S Gnanakaran; B Foley; N A Doria-Rose; B T Korber; N L Haigwood
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Human immunodeficiency virus fusion to dendritic cells declines as cells mature.

Authors:  Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; David Fenard; Christian Callebaut; Warner C Greene
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 5.  HIV gp120: double lock strategy foils host defences.

Authors:  Q J Sattentau
Journal:  Structure       Date:  1998-08-15       Impact factor: 5.006

Review 6.  Antibody vs. HIV in a clash of evolutionary titans.

Authors:  Dennis R Burton; Robyn L Stanfield; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-11       Impact factor: 11.205

7.  The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.

Authors:  Carolina Herrera; Per Johan Klasse; Elizabeth Michael; Shivani Kake; Kelly Barnes; Christopher W Kibler; Lila Campbell-Gardener; Zhihai Si; Joseph Sodroski; John P Moore; Simon Beddows
Journal:  Virology       Date:  2005-07-20       Impact factor: 3.616

8.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.

Authors:  F Gao; E Bailes; D L Robertson; Y Chen; C M Rodenburg; S F Michael; L B Cummins; L O Arthur; M Peeters; G M Shaw; P M Sharp; B H Hahn
Journal:  Nature       Date:  1999-02-04       Impact factor: 49.962

9.  Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

Authors:  Ming Zhang; Brian Gaschen; Wendy Blay; Brian Foley; Nancy Haigwood; Carla Kuiken; Bette Korber
Journal:  Glycobiology       Date:  2004-06-02       Impact factor: 4.313

10.  The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function.

Authors:  Mark J Hollier; Nigel J Dimmock
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

View more
  6 in total

1.  Different Expression of Interferon-Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells Based on Their Maturation State.

Authors:  Esther Calonge; Mercedes Bermejo; Francisco Diez-Fuertes; Isabelle Mangeot; Nuria González; Mayte Coiras; Laura Jiménez Tormo; Javier García-Perez; Nathalie Dereuddre-Bosquet; Roger Le Grand; José Alcamí
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domains.

Authors:  Marielle Cavrois; Jason Neidleman; Mario L Santiago; Cynthia A Derdeyn; Eric Hunter; Warner C Greene
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 3.  Dissecting How CD4 T Cells Are Lost During HIV Infection.

Authors:  Gilad Doitsh; Warner C Greene
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

4.  Target silencing of components of the conserved oligomeric Golgi complex impairs HIV-1 replication.

Authors:  Sicen Liu; Monika Dominska-Ngowe; Derek Michael Dykxhoorn
Journal:  Virus Res       Date:  2014-08-30       Impact factor: 3.303

5.  HIV-1 Fusion Assay.

Authors:  Marielle Cavrois; Jason Neidleman; Warner C Greene
Journal:  Bio Protoc       Date:  2014-08-20

6.  Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms.

Authors:  Michael S Harper; Kejun Guo; Kathrin Gibbert; Eric J Lee; Stephanie M Dillon; Bradley S Barrett; Martin D McCarter; Kim J Hasenkrug; Ulf Dittmer; Cara C Wilson; Mario L Santiago
Journal:  PLoS Pathog       Date:  2015-11-03       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.